FDA panel questions Janssen data in booster debate
AP, 16 Oct 2021
Johnson & Johnson executives have pitched a booster as a way to strengthen a robust vaccine that they said has retained its protective power over eight months. But FDA scientists pointedly challenged that assertion on Friday. (Oct. 15)
Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Instagram: https://www.instagram.com/APNews/
You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/1008bf930ec94dc9af649a6e0643f659